left-caret

NEWS

Paul Hastings Advised Keensight Capital in the Acquisition of Inke

June 07, 2023

Paul Hastings (Europe) LLP advised Keensight Capital in connection with the acquisition of Inke, a specialized inhalation active pharmaceutical ingredients (APIs) developer and manufacturer, previously owned by the Neuraxpharm Group.

Corporate partner Olivier Deren led the Paul Hastings team, which also included associate Vincent Nacinovic on contractual and corporate aspects, as well as partner Allard de Waal on the tax aspects.

More details on the transactions can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.

Practice Areas

Corporate

Tax

Europe

Private Equity


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment

Becca Hatton

Paris

Katy Foster

Europe

Miranda Ward

Submission Requests

Firmwide Inquiries

Elliott Frieder